| Application no. and date | 15180371.5 (espacenet) (Federated) (European Patent Register), 20050721 | | Patent/reg. no. and date | DK/EP 3018204, 20170412 | | Publication date | 20160511 | | Priority no. and date | US 939262, 20040910 | | EP pub. no. and date |
EP 3018204 20160511 | | Effective date | | | Applicant/owner | Ansun Biopharma, Inc., 3030 Callan Road
San Diego CA 92121, US | | Applicant ref. no. | P22731DKEP | | Inventor | FANG, Fang, 11124 Corte Plano Verano,
San Diego,
California 92130, US,
MALAKHOV, Michael, 1578 Indiana St.
Apt. 8
San Francisco,
California 94107, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/47 (2006.01) , A61K 39/00 (2006.01) , C07H 21/04 (2006.01) , C12N 1/20 (2006.01) , C12N 15/00 (2006.01) , C12N 9/24 (2006.01) | | Title | NY KLASSE AF TERAPEUTISK PROTEINBASEREDE MOLEKYLER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
